Development and Validation of a Japanese Version of the Inflammatory Bowel Disease Self-efficacy Scale and Cross-culture Study in Japan and the United States.

A self-efficacy scale adapted for Japanese patients with inflammatory bowel disease was found to be reliable and valid. Low self-efficacy, especially in "managing stress and emotion" domain, was observed more in Japanese patients than patients in the United States.